Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders
Daniel J. Foster, P. Jeffrey Conn
Neuron (2017) Vol. 94, Iss. 3, pp. 431-446
Open Access | Times Cited: 218

Showing 1-25 of 218 citing articles:

Dopamine: Functions, Signaling, and Association with Neurological Diseases
Marianne Klein, Daniella S. Battagello, Ariel R. Cardoso, et al.
Cellular and Molecular Neurobiology (2018) Vol. 39, Iss. 1, pp. 31-59
Closed Access | Times Cited: 794
Free Fatty Acid Receptors in Health and Disease
Ikuo Kimura, Atsuhiko Ichimura, Ryuji Ohue‐Kitano, et al.
Physiological Reviews (2019) Vol. 100, Iss. 1, pp. 171-210
Open Access | Times Cited: 706
Mechanisms of signalling and biased agonism in G protein-coupled receptors
Denise Wootten, Arthur Christopoulos, Maria Martí-Solano, et al.
Nature Reviews Molecular Cell Biology (2018) Vol. 19, Iss. 10, pp. 638-653
Open Access | Times Cited: 584
Glutamatergic Signaling in the Central Nervous System: Ionotropic and Metabotropic Receptors in Concert
Andreas Reiner, Joshua Levitz
Neuron (2018) Vol. 98, Iss. 6, pp. 1080-1098
Open Access | Times Cited: 498
Current Concepts and Treatments of Schizophrenia
Piotr Stępnicki, Magda Kondej, Agnieszka A. Kaczor
Molecules (2018) Vol. 23, Iss. 8, pp. 2087-2087
Open Access | Times Cited: 460
Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia
Jean Claude Martel, Silvia Gatti McArthur
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 189
Optical control of neuronal ion channels and receptors
Pierre Paoletti, Graham C. R. Ellis‐Davies, Alexandre Mourot
Nature reviews. Neuroscience (2019) Vol. 20, Iss. 9, pp. 514-532
Open Access | Times Cited: 166
Activation pathway of a G protein-coupled receptor uncovers conformational intermediates as targets for allosteric drug design
Shaoyong Lu, Xinheng He, Zhao Yang, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 166
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Mingyang Zhang, Ting Chen, Xun Lu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 100
Muscarinic Acetylcholine Receptor Agonists as Novel Treatments for Schizophrenia
Steven M. Paul, Samantha E. Yohn, Michael Popiolek, et al.
American Journal of Psychiatry (2022) Vol. 179, Iss. 9, pp. 611-627
Closed Access | Times Cited: 78
Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts
Eric A. Wold, Jianping Chen, Kathryn A. Cunningham, et al.
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 1, pp. 88-127
Open Access | Times Cited: 132
Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug–Target Interactions
Shaoyong Lu, Jian Zhang
Journal of Medicinal Chemistry (2018) Vol. 62, Iss. 1, pp. 24-45
Closed Access | Times Cited: 128
An inter‐dimer allosteric switch controls NMDA receptor activity
Jean‐Baptiste Esmenjaud, David Stroebel, Kelvin Chan, et al.
The EMBO Journal (2018) Vol. 38, Iss. 2
Open Access | Times Cited: 123
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Estefanía Moreno, Milena Čavić, Ana Krivokuća, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 110
Targeting Muscarinic Acetylcholine Receptors for the Treatment of Psychiatric and Neurological Disorders
Sean P. Moran, James Maksymetz, P. Jeffrey Conn
Trends in Pharmacological Sciences (2019) Vol. 40, Iss. 12, pp. 1006-1020
Open Access | Times Cited: 107
β-amyloid redirects norepinephrine signaling to activate the pathogenic GSK3β/tau cascade
Fang Zhang, Mary Gannon, Yunjia Chen, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 526
Open Access | Times Cited: 107
Silent Allosteric Modulation of mGluR5 Maintains Glutamate Signaling while Rescuing Alzheimer’s Mouse Phenotypes
Laura T. Haas, Santiago V. Salazar, Levi M. Smith, et al.
Cell Reports (2017) Vol. 20, Iss. 1, pp. 76-88
Open Access | Times Cited: 99
Metabotropic glutamate receptor subtype 2 is a cellular receptor for rabies virus
Jinliang Wang, Zilong Wang, Renqiang Liu, et al.
PLoS Pathogens (2018) Vol. 14, Iss. 7, pp. e1007189-e1007189
Open Access | Times Cited: 92
The GABAB Receptor—Structure, Ligand Binding and Drug Development
Linn Samira Mari Evenseth, Mari Gabrielsen, Ingebrigt Sylte
Molecules (2020) Vol. 25, Iss. 13, pp. 3093-3093
Open Access | Times Cited: 88
Mechanism of dopamine binding and allosteric modulation of the human D1 dopamine receptor
Youwen Zhuang, B. Krumm, Huibing Zhang, et al.
Cell Research (2021) Vol. 31, Iss. 5, pp. 593-596
Open Access | Times Cited: 74
Targeting muscarinic receptors to treat schizophrenia
Daniel J. Foster, Zoey Bryant, P. Jeffrey Conn
Behavioural Brain Research (2021) Vol. 405, pp. 113201-113201
Open Access | Times Cited: 67
Short-Chain Fatty Acid Receptors and Cardiovascular Function
Anastasios Lymperopoulos, Malka S. Suster, Jordana I. Borges
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3303-3303
Open Access | Times Cited: 67
Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1
Xin Yang, Xuehui Wang, Zheng Xu, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 8, pp. 831-840
Closed Access | Times Cited: 63
Conformational rearrangement during activation of a metabotropic glutamate receptor
Brandon W. Liauw, Hamid Samareh Afsari, Reza Vafabakhsh
Nature Chemical Biology (2021) Vol. 17, Iss. 3, pp. 291-297
Open Access | Times Cited: 57
Selective activation of Gαob by an adenosine A1 receptor agonist elicits analgesia without cardiorespiratory depression
Mark J. Wall, Emily Hill, Robert Huckstepp, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top